Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022

Stock Price vs Company Growth
1d
0.7%
1w
4.7%
1m
15.4%
3m
20.8%
6m
26.7%
1y
5.4%
all
0.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 193 0.7%
156
196
Company Overview

Sales
8,869 Cr
Growth: 0.2%
Profit after Tax
-347 Cr
Growth: 88.0%
Mid Cap
25,748 Cr
P/S: 2.9x
Industry P/S: 2.7x
Fundamentals

Sales (Cr) ₹ 8,869
Growth 0.2%
EBITDA 10.4%
P/S 2.9x
Dividend 0.1%
P/E -78.3x
Book Value ₹ 61.3
PEG Ratio -502.0x
ROE -4.3%
P/B 3.1x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the India’s largest Pharmaceutical Company. PPL offers a portfolio of differentiated products and services through its global development and manufacturing facilities and a global distribution network in various countries.
Investors (6)
Followers (2)